AI SummaryBeta
MoonLake Immunotherapeutics focuses on office space investments, recently leasing 13,500 square feet at 601 Brickell Key Drive. The company has been an active player since November 2026, with a team size of 1.
AI-generated from Traded deal data. May contain errors.
About
MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing innovative therapies using its proprietary Nanobody® technology. Founded in 2021, the company is publicly traded on the Nasdaq under the symbol MLTX and has recently established its U.S. headquarters in Miami, Florida.
Focus
Office
Lease
Markets
Headquarters
Miami, Florida, United States
FAQs
MoonLake Immunotherapeutics has financed 1 deal.
MoonLake Immunotherapeutics's most recent deal was on November 09, 2026.
Member since: November 2026